Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

EAACI launches first World Anaphylaxis Awareness Day

The day is aimed at raising awareness of severe allergic reaction, and promoting prevention and management

- PMLiVE

Pfizer appoints Chris Boshoff as chief scientific officer and president of R&D

Boshoff has most recently been serving as the company’s chief oncology officer and executive vice president

- PMLiVE

Measuring outcomes in medical affairs – the key components to be considered

By Caroline Phillips

- PMLiVE

UCB’s Bimzelx granted FDA approval to treat hidradenitis suppurativa in adults

The inflammatory skin disease affects approximately one in every 100 people in the US

- PMLiVE

Is the new Health and Social Care Select Committee a battleground or consensus opportunity?

By Andie Gbedemah

- PMLiVE

Bringing more effective storytelling to medical publications

By Nicole Parker, Kristen Quinn and Stephen Towers

- PMLiVE

Health Awareness V Health Anxiety: Is the increase of online health content a help or hindrance?

Medical Writer, Steph Gathercole, looks at the impact increased access to online health information has on the public through the lens of Anxiety

Mednet

Biogen Idec building

Biogen/Eisai’s Alzheimer’s drug lecanemab receives CHMP recommendation

The neurodegenerative disorder affects an estimated 6.9 million people in Europe

- PMLiVE

The potential of generative AI and its practical application in the world of promotional medical communications

By Markus Vaga and Dave Ferguson

- PMLiVE

Impending ESG regulations present communications opportunity for pharma

By Trey Watkins and Gemma Medcalf

- PMLiVE

Insights and reflections from the Mtech Access transforming healthcare symposium

Our transforming healthcare symposium was held on Tuesday 5th November 2024. In this article, Prof Phil Richardson (Chief Innovation Officer, Mtech Access) shares his reflections from the day.

Petauri Evidence

- PMLiVE

EU Joint Clinical Assessment (JCA) – Implications for Pharma and Medtech

Katie Rose (Consultant – Market Access), Maria Dimitrova (Consultant – HTA) and Samantha Gillard (Director – HTA) provide an overview of the EU Joint Clinical Assessment (JCA) and what it...

Petauri Evidence

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links